Product Information
BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE is a generic product labeled by Sandoz Inc., priced at $0.9750 per EA under NDC 00781227001. Its NADAC has been published 86 times since Nov 6, 2024.
Strength
325; 50; 40 mg/1; mg/1; mg/1
Manufacturer
Sandoz Inc.NDC
00781227001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ASPIRIN; BUTALBITAL; CAFFEINEApproval Type
Generic (ANDA)
FDA Application
ANDA086996On Market Since
9/3/2024
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has been published 86 times since Nov 6, 2024, and over the history we have for it it has risen 30.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9750 per EA |
|---|---|
| All-time high | $1.0486 (Sep 10, 2025) |
| All-time low | $0.3623 (Nov 20, 2024) |
| 52-week high | $1.0486 |
| 52-week low | $0.9704 |
| Median price | $0.9797 |
| Average price | $0.9100 |
| Largest weekly change | +59.7% (Dec 18, 2024) |
| Weeks tracked | 86 |
| Tracking since | Nov 6, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, manufactured by Sandoz Inc., is $0.9750 per EA (NDC 00781227001), effective Jun 24, 2026.
How has the price of BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has risen 30.1%. It has been tracked across 86 weekly CMS publications since Nov 6, 2024.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
Since Nov 6, 2024, the NADAC for BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE has ranged from a low of $0.3623 (Nov 20, 2024) to a high of $1.0486 (Sep 10, 2025), with a median of $0.9797 per EA.
Are there cheaper alternatives to BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE, but none are currently priced below it.
Who manufactures BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE?
BUTALBITAL-ASPIRIN-CAFFEINE 50-325-40 MG CAPSULE (NDC 00781227001) is labeled by Sandoz Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification